reference/3392543

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3392543

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial
endingPage	1152
issn	0953-7104 1369-1635
issueIdentifier	8
pageRange	1146-1152
publicationName	Platelets
startingPage	1146
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9302523043adca1bba457810a2f03369
bibliographicCitation	He M, Yan W, Zhang Y, Kong Y, Han X, Ren J, Zhao Z, Liu G, Shi J, Li Y. Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity: a randomized, crossover clinical study (SINGLE study). Platelets. 2022 Nov 17;33(8):1146–52. doi: 10.1080/09537104.2022.2052036. PMID: 35379064.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3022adfbbdf8ee2a48f47272cfa1b8ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9eeb5dd5d5e0735a34968c3bc47fd516 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4e3b3a4eab46e049386dcdb1be7ed7e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b79004852c791b2dffd64a2f00a805b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bed9641e783763a73acfb0997054650 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f15f3c524da1dbf3e66c054a21e0861 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_314199e1044ff82a7060432d41b05a49 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_014d7a090421a4ecab5f654546e02530 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62592b92368c68c2a2a30799f11a65f0
date	2022-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1080/09537104.2022.2052036 https://pubmed.ncbi.nlm.nih.gov/35379064
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21801 https://portal.issn.org/resource/ISSN/0953-7104 https://portal.issn.org/resource/ISSN/1369-1635
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity: a randomized, crossover clinical study (SINGLE study)
discusses	http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0000380 http://id.nlm.nih.gov/mesh/M0008434 http://id.nlm.nih.gov/mesh/M0155432 http://id.nlm.nih.gov/mesh/M0000377 http://id.nlm.nih.gov/mesh/M0007583 http://id.nlm.nih.gov/mesh/M0513890
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D010975Q000494 http://id.nlm.nih.gov/mesh/D005343Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001241Q000494 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000241Q000627 http://id.nlm.nih.gov/mesh/D001792 http://id.nlm.nih.gov/mesh/D000077144Q000627 http://id.nlm.nih.gov/mesh/D000077486Q000627 http://id.nlm.nih.gov/mesh/D000077144Q000494 http://id.nlm.nih.gov/mesh/D000244Q000494 http://id.nlm.nih.gov/mesh/D010974 http://id.nlm.nih.gov/mesh/D004837Q000494 http://id.nlm.nih.gov/mesh/D018592 http://id.nlm.nih.gov/mesh/D000077486Q000494
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7347 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871419 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f74135abcce785031995f1a87552cf78

Total number of triples: 64.